Resona Asset Management’s Royalty Pharma RPRX Stock Holding History

Resona Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.17M	Sell	109,991 -8,965	-8%	-$467K	0.03%	435
2026 Q1	$5.71M	Buy	118,956 +4,046	+4%	+$177K	0.03%	452
2025 Q4	$4.44M	Buy	114,910 +474	+0.4%	+$18.1K	0.02%	512
2025 Q3	$4.04M	Buy	114,436 +4,006	+4%	+$145K	0.02%	533
2025 Q2	$3.98M	Buy	+110,430	New	+$3.66M	0.02%	533

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Resona Asset Management's RPRX Position: Q2 2026 in Review

Resona Asset Management reduced its Royalty Pharma (RPRX) stake by 7.5% in Q2 2026, selling an estimated $467K and leaving 109,991 shares worth $6.17M. The position accounts for 0.03% of the portfolio, ranked #435.

Resona Asset Management first reported a position in RPRX in Q2 2025 and has held it in 5 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Resona Asset Management held 109,991 shares of Royalty Pharma worth $6.17M as of Q2 2026.
Resona Asset Management sold 8,965 Royalty Pharma shares in Q2 2026, an estimated $467K.
Royalty Pharma made up 0.03% of Resona Asset Management's portfolio in Q2 2026, its #435 holding.
Resona Asset Management first reported a position in Royalty Pharma in Q2 2025 and has held it in 5 quarters since.
647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.